Abstract: Cidofovir or foscarnet based compounds having an amino acid or dipeptide esters are provided as prodrugs.
Type:
Grant
Filed:
March 16, 2009
Date of Patent:
November 22, 2011
Assignees:
TSRL, Inc., National Institute of Health (NIH), The United States of America as represented by the Department of Health and Human Services (DHHS), The United States of America as represented by the NIH Division of Extramural Inventions and Technology Resources (DEITR)
Inventors:
John Hilfinger, Charles E. McKenna, Boris A. Kashemirov, Chi Pham, Kanokkarn Saejueng, Larryn Peterson
Abstract: Small molecule polycationic agents are used to modulate or interrupt biological processes by binding to oligosaccharide-based biomolecules. Compounds that inhibit nitric oxide, TNF? or other immunomodulators are provided and are useful for treating immunological disease and disease of an infectious disorder.
Type:
Grant
Filed:
March 30, 2007
Date of Patent:
February 16, 2010
Assignees:
National Institutes of Health (NIH), The United States of America as represented by the Department of Health and Human Services (DHHS)